Medikaloka Hermina Tbk PT
IDX:HEAL
Medikaloka Hermina Tbk PT
IDX:HEAL
Price:
1 595
IDR
3.91%
Market Closed
Market Cap:
24.5T
IDR
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
HEAL Alert
Medikaloka Hermina Tbk PT
1595
+60 (+3.91%)
| 52 Week Range |
1 070
1 595
|
| Price Target |
|
We'll email you a reminder when the closing price reaches IDR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
Medikaloka Hermina Tbk PT
Balance Sheet
Balance Sheet Decomposition
Medikaloka Hermina Tbk PT
Medikaloka Hermina Tbk PT
| Current Assets | 2T |
| Cash & Short-Term Investments | 672.3B |
| Receivables | 1.2T |
| Other Current Assets | 141.2B |
| Non-Current Assets | 8.2T |
| PP&E | 7.8T |
| Other Non-Current Assets | 351.5B |
| Current Liabilities | 1.6T |
| Accounts Payable | 354.3B |
| Accrued Liabilities | 191.4B |
| Short-Term Debt | 55.2B |
| Other Current Liabilities | 1T |
| Non-Current Liabilities | 4.2T |
| Long-Term Debt | 2.7T |
| Other Non-Current Liabilities | 1.5T |
Balance Sheet
Medikaloka Hermina Tbk PT
Medikaloka Hermina Tbk PT
Currency: IDR
| Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & Cash Equivalents |
118 820
|
203 171
|
322 427
|
303 801
|
593 255
|
864 577
|
1 286 518
|
774 947
|
855 212
|
|
| Cash |
118 820
|
203 171
|
322 427
|
303 801
|
593 255
|
864 577
|
1 286 518
|
774 947
|
855 212
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
121 157
|
326
|
441
|
431
|
|
| Total Receivables |
186 280
|
345 225
|
547 249
|
861 283
|
1 009 175
|
1 174 468
|
1 071 639
|
898 385
|
963 017
|
|
| Accounts Receivables |
157 585
|
293 212
|
493 624
|
777 101
|
926 497
|
1 113 254
|
1 002 458
|
833 721
|
885 194
|
|
| Other Receivables |
28 695
|
52 013
|
53 625
|
84 182
|
82 678
|
61 214
|
69 181
|
64 664
|
77 823
|
|
| Inventory |
31 436
|
44 494
|
45 495
|
55 368
|
51 215
|
81 846
|
94 640
|
100 029
|
117 430
|
|
| Other Current Assets |
46 186
|
8 072
|
7 286
|
8 120
|
10 843
|
10 354
|
12 570
|
16 860
|
14 006
|
|
| Total Current Assets |
382 722
|
600 962
|
922 457
|
1 228 572
|
1 664 488
|
2 252 402
|
2 465 693
|
1 790 662
|
1 950 096
|
|
| PP&E Net |
1 331 745
|
1 682 235
|
2 219 402
|
2 827 316
|
3 241 738
|
3 956 182
|
4 886 437
|
5 504 325
|
6 531 048
|
|
| PP&E Gross |
1 331 745
|
1 682 235
|
2 219 402
|
2 827 316
|
3 241 738
|
3 956 182
|
4 886 437
|
5 504 325
|
6 531 048
|
|
| Accumulated Depreciation |
574 118
|
642 229
|
789 587
|
974 418
|
1 186 062
|
1 463 737
|
1 875 724
|
2 396 625
|
2 985 670
|
|
| Note Receivable |
11 850
|
174 622
|
137 391
|
26 651
|
25 273
|
2 745
|
2 745
|
20 643
|
30 355
|
|
| Long-Term Investments |
17 870
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
37 940
|
43 678
|
67 375
|
88 668
|
116 288
|
143 925
|
231 284
|
275 855
|
291 152
|
|
| Total Assets |
1 782 127
N/A
|
2 501 497
+40%
|
3 346 625
+34%
|
4 171 207
+25%
|
5 047 787
+21%
|
6 355 254
+26%
|
7 586 159
+19%
|
7 591 485
+0%
|
8 802 651
+16%
|
|
| Liabilities | ||||||||||
| Accounts Payable |
112 397
|
132 293
|
177 540
|
203 395
|
207 724
|
295 868
|
324 354
|
281 730
|
355 750
|
|
| Accrued Liabilities |
33 256
|
37 738
|
61 314
|
100 400
|
128 350
|
152 719
|
159 054
|
156 701
|
165 810
|
|
| Short-Term Debt |
0
|
0
|
732 711
|
0
|
46 497
|
9 050
|
29 448
|
0
|
48 223
|
|
| Current Portion of Long-Term Debt |
61 401
|
106 843
|
133 709
|
264 751
|
183 605
|
258 798
|
162 548
|
574 974
|
209 972
|
|
| Other Current Liabilities |
250 658
|
405 327
|
616 681
|
471 492
|
478 154
|
763 223
|
941 668
|
696 635
|
773 074
|
|
| Total Current Liabilities |
457 712
|
682 201
|
1 721 955
|
1 040 038
|
1 044 330
|
1 479 658
|
1 617 072
|
1 710 040
|
1 552 829
|
|
| Long-Term Debt |
292 712
|
506 916
|
561 809
|
601 037
|
1 064 544
|
1 297 595
|
1 474 537
|
1 162 377
|
2 002 702
|
|
| Deferred Income Tax |
0
|
0
|
4 974
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
52 592
|
67 609
|
502 201
|
503 913
|
617 225
|
830 133
|
1 117 155
|
1 244 649
|
1 329 208
|
|
| Other Liabilities |
74 115
|
52 420
|
101 358
|
160 423
|
174 479
|
195 824
|
108 295
|
33 595
|
48 794
|
|
| Total Liabilities |
877 131
N/A
|
1 309 146
+49%
|
2 892 297
+121%
|
2 305 411
-20%
|
2 900 578
+26%
|
3 803 210
+31%
|
4 317 059
+14%
|
4 150 661
-4%
|
4 933 533
+19%
|
|
| Equity | ||||||||||
| Common Stock |
24 000
|
199 000
|
252 689
|
297 300
|
297 300
|
297 800
|
297 800
|
299 121
|
300 697
|
|
| Retained Earnings |
119 912
|
144 256
|
317 215
|
262 683
|
18 730
|
464 157
|
1 410 145
|
1 670 953
|
1 992 710
|
|
| Additional Paid In Capital |
3 302
|
3 405
|
518 854
|
1 831 179
|
1 831 179
|
1 850 679
|
1 850 679
|
1 923 657
|
2 028 618
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
60 592
|
289 524
|
452 907
|
452 907
|
|
| Other Equity |
757 782
|
845 690
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
904 996
N/A
|
1 192 351
+32%
|
454 328
-62%
|
1 865 796
+311%
|
2 147 209
+15%
|
2 552 044
+19%
|
3 269 100
+28%
|
3 440 824
+5%
|
3 869 118
+12%
|
|
| Total Liabilities & Equity |
1 782 127
N/A
|
2 501 497
+40%
|
3 346 625
+34%
|
4 171 207
+25%
|
5 047 787
+21%
|
6 355 254
+26%
|
7 586 159
+19%
|
7 591 485
+0%
|
8 802 651
+16%
|
|
| Shares Outstanding | ||||||||||
| Common Shares Outstanding |
240
|
9 950
|
12 634
|
14 865
|
14 865
|
14 800
|
14 561
|
14 480
|
14 559
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
